ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,333Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 656

$1.83M Total Retail Price of All Prescriptions

Rank: 8 out of 656

1,015 Patients Receiving at Least One Drug in Part D
58%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 1,015 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

3% of this provider’s 5,090 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$149 was the average price of a prescription from this provider, compared to $147 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
RISPERIDONE 1,169 607 1 2
TRAZODONE HCL 624 204 2 1
DIVALPROEX SODIUM ER 592 108 3 10
BENZTROPINE MESYLATE 464 94 R 4 4
DIVALPROEX SODIUM 424 262 5 24
QUETIAPINE FUMARATE 420 159 6 5
CYMBALTA 383 218 7 7
SERTRALINE HCL 373 156 8 8
CITALOPRAM HBR 346 190 9 9
ESCITALOPRAM OXALATE 338 226 10 18
OLANZAPINE 314 112 11 12
ZOLPIDEM TARTRATE 295 101 12 3
ABILIFY 291 89 13 6
LAMOTRIGINE 269 84 14 14
NAMENDA 266 251 15 22
MIRTAZAPINE 254 201 16 13
SEROQUEL XR 249 83 17 21
FLUOXETINE HCL 236 64 18 11
OXCARBAZEPINE 224 68 19 28
DONEPEZIL HCL 223 222 20 33
HALOPERIDOL 211 64 21 26
EXELON 203 186 22 36
ZIPRASIDONE HCL 191 59 23 27
LITHIUM CARBONATE 190 40 24 16
FLUVOXAMINE MALEATE 180 27 25 63
SEROQUEL 147 71 26 20
LATUDA 147 42 26 46
LEXAPRO 139 88 28 47
VENLAFAXINE HCL ER 126 65 29 15
BUPROPION XL 126 31 29 17
NUEDEXTA 112 22 31 109
PAROXETINE HCL 107 43 32 23
MEDROXYPROGESTERONE ACETATE 104 65 33 126
RISPERDAL CONSTA 103 42 34 40
CLOMIPRAMINE HCL 103 23 R 34 108
CARBAMAZEPINE 102 0 36 35
PROPRANOLOL HCL 98 47 37 49
GEODON 91 26 38 57
TOPIRAMATE 83 38 39 34
OLANZAPINE ODT 81 22 40 64
INVEGA 80 0 41 38
LUNESTA 76 14 42 51
BUPROPION HCL SR 73 29 43 25
VALPROIC ACID 72 40 44 69
GUANFACINE HCL 56 0 R 45 100
CARBAMAZEPINE XR 51 0 46 107
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 11, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.